Press release

Press Release

Cision PR Newswire2 weeks ago
0

GOLD ROYALTY TO ACQUIRE PRODUCING PEDRA BRANCA GOLD AND COPPER ROYALTY

VANCOUVER, BC, Dec. 8, 2025 /PRNewswire/ – Gold Royalty Corp. (“Gold Royalty” or the “Company“) (NYSE American: GROY) is pleased to…
Read More »
Business Wire2 weeks ago

PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis

Feedback from U.S. Food and Drug Administration (FDA) supports advancement into a pivotal Phase 3 trial and a 505(b)(2) regulatory…
Read More »
Business Wire2 weeks ago

Merz Therapeutics to Present Broad Range of Clinical, Real-World and Mechanistic Data at TOXINS 2026

Merz Therapeutics to present more than 20 abstracts and posters at the TOXINS 2026 8th International Conference, taking place January…
Read More »
Business Wire2 weeks ago

BigBear.ai Expands to Middle East with UAE Office to Advance AI Innovation for Global Security

CEO Kevin McAleenan highlights travel and trade as national security imperatives during Global AI Show keynote ABU DHABI, United Arab…
Read More »
Cision PR Newswire2 weeks ago
0

EQT agrees to sale of shares in Galderma Group AG to L’Oréal S.A.

C. 24 million shares to be sold STOCKHOLM, Dec. 8, 2025 /PRNewswire/ — Further to previous announcements, an affiliate of…
Read More »
Business Wire2 weeks ago

Sensorion Reports Independent Data Monitoring Committee Raises No Safety Concerns and Agrees to Continue SENS-501’s Audiogene Phase 1/2 Trial

MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies…
Read More »
Business Wire2 weeks ago

3D Investment Releases a Presentation Highlighting Management Issues at SQEX Holdings and Seeks Shareholder Views

TOKYO–(BUSINESS WIRE)–3D Investment Partners Pte. Ltd. (“3D” or the “Company”), an independent investment management firm providing discretionary investment services to…
Read More »
Press Release

Cision PR Newswire2 weeks ago
0

GC Biopharma Ships First Doses of World’s First Recombinant Anthrax Vaccine, ‘BARYTHRAX inj.’

– First anthrax vaccine developed using recombinant DNA technology– Annual production capacity of up to 10 million doses at GC…
Read More »
Press Release

Cision PR Newswire2 weeks ago
0

UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder

Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction in countable motor seizure frequency (CMSF)…
Read More »
Business Wire2 weeks ago

HAFNIA LIMITED: Ex Dividend USD 0.1470 on the Oslo Stock Exchange Today

SINGAPORE–(BUSINESS WIRE)–Reference is made to the stock exchange announcements made by Hafnia Limited (“Hafnia” or the “Company”, OSE ticker code:…
Read More »

Previous page Next page